Allarity Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Allarity Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2023 to Q2 2024.
  • Allarity Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was -$22K, a 112% decline year-over-year.
  • Allarity Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.15M, a 41.4% increase from 2021.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$22K -$202K -112% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $32K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q2 2023 $180K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.